Literature DB >> 4533707

Flupenthixol decanoate--in treatment of out-patients.

C G Gottfries, L Green.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1974        PMID： 4533707     DOI： 10.1111/j.1600-0447.1974.tb08890.x

Source DB:  PubMed          Journal:  Acta Psychiatr Scand Suppl        ISSN： 0065-1591


× No keyword cloud information.
  7 in total

Review 1.  The role of long-acting injectable antipsychotics in schizophrenia: a critical appraisal.

Authors:  Sofia Brissos; Miguel Ruiz Veguilla; David Taylor; Vicent Balanzá-Martinez
Journal:  Ther Adv Psychopharmacol       Date:  2014-10

2.  Treatment of chronic schizophrenia.

Authors:  D A Johnson
Journal:  Drugs       Date:  1977-10       Impact factor: 9.546

3.  Comparison of serum levels after intramuscular injections of 2% and 10% cis(Z)-flupentixol decanoate in Viscoleo to schizophrenic patients.

Authors:  J A Stauning; L Kirk; A Jøorgensen
Journal:  Psychopharmacology (Berl)       Date:  1979-09       Impact factor: 4.530

Review 4.  Patient compliance with drug therapy in schizophrenia. Economic and clinical issues.

Authors:  E Lindström; K Bingefors
Journal:  Pharmacoeconomics       Date:  2000-08       Impact factor: 4.981

Review 5.  Long-term depot antipsychotics. A risk-benefit assessment.

Authors:  T R Barnes; D A Curson
Journal:  Drug Saf       Date:  1994-06       Impact factor: 5.606

Review 6.  Depot antipsychotic drugs. Place in therapy.

Authors:  J M Davis; L Matalon; M D Watanabe; L Blake; L ] Metalon L [corrected to Matalon
Journal:  Drugs       Date:  1994-05       Impact factor: 9.546

Review 7.  Flupenthixol decanoate (depot) for schizophrenia or other similar psychotic disorders.

Authors:  Jataveda Mahapatra; Seema N Quraishi; Anthony David; Stephanie Sampson; Clive E Adams
Journal:  Cochrane Database Syst Rev       Date:  2014-06-10
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.